Article

In the management of adults with cerebral palsy (CP), one of the goals
is to monitor and prevent spasticity-related deteriorations in gait. Botulinum
Toxin Injections (BTI) are commonly used to treat this spasticity in these
patients. The purpose of this study was to evaluate (i) the effect of multi-site
BTI on gait patterns in adults with CP and (ii) to determine if these
modifications could be detected by the Gait Deviation Index (GDI). METHOD:
Spontaneous-velocity gait was recorded using 3D gait analysis before and 1 month
after multi-site BTI in lower limb muscles. Spatiotemporal parameters (STP),
kinematic parameters (KP) and the GDI were computed. RESULTS: Post BTI, stride
length, peak hip flexion and peak knee flexion during Swing Phase (SW) were
significantly increased while the GDI was not significantly modified. CONCLUSION:
A single multi-site BTI improved STP and KP of adults with CP but the GDI was not
sensitive enough to detect these changes. Implications for Rehabilitation Only
few study on adults with cerebral palsy BTI approach on the gait patterns are
largely unknown. BTI session induced only some smaller improvement of KP and STP.
This improvement did not modify the GDI. We cannot determine if GDI is a relevant
tool to evaluate changes following BTI or other types of treatment.

Langue : ANGLAIS